Lockshin Curtis
Insider CIK 1383556 · CDXC.OB Director · RXII Director · XBIO Chief Scientific Officer · SRNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHIO Phio Pharmaceuticals Corp. | A Award | 2026-02-05 | 2026-02-06 | 16,600 | — | $0 | 35,155 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2025-09-11 | 2025-09-15 | 16,200 | — | $0 | 18,555 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2024-09-11 | 2024-09-12 | 2,000 | — | $0 | 2,000 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2023-12-11 | 2023-12-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2023-02-17 | 2023-02-22 | 1,500 | — | $0 | 3,197 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2022-03-24 | 2022-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2022-02-15 | 2022-02-16 | 10,000 | — | $0 | 20,366 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2021-03-18 | 2021-03-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2021-03-01 | 2021-03-03 | 10,000 | — | $0 | 10,366 | SEC↗ |
| XBIO Xenetic Biosciences, Inc. | A Award deriv | 2019-12-04 | 2019-12-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PHIO Phio Pharmaceuticals Corp. | A Award | 2019-02-13 | 2019-02-15 | 10,000 | — | $0 | 20,130 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award | 2018-08-01 | 2018-08-03 | 10,000 | — | $0 | 10,130 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2017-02-01 | 2017-02-03 | 2,000 | — | $0 | 2,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2016-02-10 | 2016-02-12 | 16,666 | — | $0 | 16,666 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2015-06-02 | 2015-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2015-06-02 | 2015-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award | 2015-06-02 | 2015-06-03 | 12,000 | $0.40 | $4.8K | 13,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2015-06-01 | 2015-06-02 | 16,666 | — | $0 | 16,666 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2014-06-02 | 2014-06-04 | 16,666 | — | $0 | 16,666 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | P Buy | 2013-08-29 | 2013-08-30 | 1,000 | $3.70 | $3.7K | 1,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2013-04-18 | 2013-04-22 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| RXII RXi Pharmaceuticals Corp | A Award deriv | 2013-04-18 | 2013-05-03 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CDXC.OB ChromaDex Corp. | D To issuer deriv | 2012-12-21 | 2012-12-26 | 67,500 | — | $0 | 67,500 | SEC↗ |
| CDXC.OB ChromaDex Corp. | A Award deriv | 2012-12-21 | 2012-12-26 | 45,651 | — | $0 | 113,151 | SEC↗ |
| CDXC.OB ChromaDex Corp. | A Award deriv | 2012-08-28 | 2012-09-26 | 67,500 | — | $0 | 135,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-07-20 | 2012-07-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2012-02-06 | 2012-02-07 | 100,000 | — | $0 | 100,000 | SEC↗ |